Personalized tapering of tumor necrosis factor inhibitor in axial spondyloarthritis

Int J Rheum Dis. 2024 Jan;27(1):e15008. doi: 10.1111/1756-185X.15008. Epub 2023 Dec 23.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adalimumab / therapeutic use
  • Antirheumatic Agents* / adverse effects
  • Axial Spondyloarthritis*
  • Humans
  • Spondylarthritis* / diagnosis
  • Spondylarthritis* / drug therapy
  • Spondylitis, Ankylosing* / diagnosis
  • Spondylitis, Ankylosing* / drug therapy
  • Tumor Necrosis Factor Inhibitors / adverse effects
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor Inhibitors
  • Antirheumatic Agents
  • Adalimumab
  • Tumor Necrosis Factor-alpha